ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1489–1500 of 2020 project topics
Multiplexed SNP Genotyping Assay for Common CAH Mutations
A high-throughput microarray or qPCR product designed to detect the most prevalent CYP21A2 mutations with 96-well plate scalability and minimal hands-on time. This product generates high-volume consumable sales and positions the company as a preferred supplier for newborn screening programs and regional diagnostic networks.
Genetic Basis of Congenital Adrenal Hyperplasia Click to view more details →
CAH Mutation Database and Clinical Evidence Aggregation Platform
A curated, subscription-based online knowledgebase that collects published CAH genotype-phenotype correlations, treatment outcomes, and clinical guidelines for clinicians and researchers. This establishes recurring software-as-a-service revenue, builds network effects through user contributions, and creates opportunities for sponsored content and biotech partnerships.
Genetic Basis of Congenital Adrenal Hyperplasia Click to view more details →
Dravet Syndrome SCN1A Gene Testing
Developing comprehensive SCN1A testing including sequencing, MLPA, and mosaicism detection for Dravet syndrome diagnosis and precision treatment selection.
Genetic Basis of Refractory Epilepsies Click to view more details →
KCNQ2 Neonatal Epilepsy Variant Characterization
Characterizing KCNQ2 gain and loss-of-function variants causing neonatal epilepsy for genotype-guided treatment with sodium channel blockers or retigabine.
Genetic Basis of Refractory Epilepsies Click to view more details →
DEPDC5 mTOR Pathway Epilepsy Testing
Identifying DEPDC5, NPRL2, and NPRL3 variants causing focal epilepsy for molecular diagnosis and mTOR inhibitor treatment consideration.
Genetic Basis of Refractory Epilepsies Click to view more details →
Ultra-Rare Epilepsy Gene Functional Validation
Developing cell and animal model functional assays for validating pathogenicity of variants in novel epilepsy genes identified by exome sequencing.
Genetic Basis of Refractory Epilepsies Click to view more details →
PCDH19 Gene Mutation SaaS Diagnostic Platform
A cloud-based diagnostic platform that automates PCDH19 variant interpretation and phenotype correlation for Generalized Epilepsy and Paroxysmal Exertion-Induced Dyskinesia. The platform enables labs to offer rapid clinical reporting with AI-powered variant classification, generating recurring SaaS revenues through per-test licensing and institutional subscriptions.
Genetic Basis of Refractory Epilepsies Click to view more details →
ARX Gene X-linked Infantile Spasms Genetic Testing Kit
A commercial genetic testing kit targeting ARX mutations associated with Infantile Spasms and X-linked Lissencephaly, delivered as a bundled diagnostic service to pediatric neurology clinics. Revenue is generated through direct-to-consumer and clinical lab partnerships with standardized pricing per test and annual licensing fees.
Genetic Basis of Refractory Epilepsies Click to view more details →
Multi-Gene Panel Refractory Epilepsy Rapid Sequencing Service
An industry-leading next-generation sequencing service targeting 180+ known refractory epilepsy genes including SYN1, GRIN2B, and CASK with 7-day turnaround reporting. The service creates a high-margin B2B revenue stream by partnering with diagnostic labs and hospital networks worldwide.
Genetic Basis of Refractory Epilepsies Click to view more details →
Focal Cortical Dysplasia Gene Biomarker Discovery Software Tool
A proprietary bioinformatics software tool that identifies causative mutations in DCX, PTEN, MTOR, and other FCD-associated genes through machine learning variant prioritization. The tool monetizes through annual software licenses, institutional seat-based subscriptions, and pay-per-analysis consulting services for pharmaceutical companies.
Genetic Basis of Refractory Epilepsies Click to view more details →
Temporo-Mesial Lobe Epilepsy Genetic Counseling Digital Platform
A telemedicine-enabled platform connecting patients with TPLE genetic variants to certified genetic counselors and personalized treatment recommendations based on genotype-phenotype data. Revenue streams include subscription fees for patient users, B2B licensing to healthcare systems, and partnerships with pharmaceutical companies for patient recruitment.
Genetic Basis of Refractory Epilepsies Click to view more details →
Progressive Myoclonic Epilepsy Gene Therapy Candidate Screening Platform
A preclinical screening platform identifying ideal candidates for emerging gene therapies in PME by analyzing CSTB, EPM2A, SCARB2, and LAFORIN variants with functional validation assays. This B2B service generates revenue through clinical trial recruitment support, biotech partnerships, and orphan drug development consulting fees.
Genetic Basis of Refractory Epilepsies Click to view more details →